Second malignancy after treatment of childhood non-Hodgkin lymphoma
โ Scribed by Wing Leung; John T. Sandlund; Melissa M. Hudson; Yinmei Zhou; Michael L. Hancock; Yunping Zhu; Raul C. Ribeiro; Jeffrey E. Rubnitz; Larry E. Kun; Bassem Razzouk; William E. Evans; Ching-Hon Pui
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 117 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
As far as we know, this is the first report of a non-Hodgkin lymphoma developing after successful treatment of neuroblastoma. A boy was found to have a mediastinal T-cell lymphoma at the age of 5. He had been treated for a neuroblastoma of the left adrenal region 4 years before, when by intensive ch
The aim of this study was to evaluate the centrations in 20-minute blood samples colgrowth and growth hormone (GH) secretion, as lected over a 24-hour period. The plasma GH assessed by the rate and pattern of secretion, in concentrations were transformed into GH secrepatients in remission from non-H
Much of the approach to evaluation and management of the non-Hodgkin's lymphomas has been modeled after Hodgkin's disease. However, as the name implies, they are quite different. The non-Hodgkin's lymphomas are a group of diseases and syndromes. These many different presentations, syndromes, and pos
## Risk of second primary malignancy was assessed in a population-based follow-up survey of all persons who developed cutaneous T-cell lymphoma (CI'CL) in nine geographic areas of the United States covered by the Surveillance, Epidemiology and End Results (SEER) program of the National Cancer Inst